NHS
Camurus’ weekly/monthly opioid dependence injection accepted in Scotland for NHS use
August 13, 2019Manufacturing and Production, Sales and Marketing Camurus, NHS, Scotland, nhs scotland, opioid dependence, opioids, pharma
The Scottish Medicines Consortium (SMC) has announced its acceptance of Buvidal (buprenorphine prolonged-release solution for subcutaneous injection) from Swedish pharma …
Keytruda/chemo combo recommended for first-line lung cancer via Cancer Drugs Fund
August 8, 2019Sales and Marketing CDF, Cancer, MSD, NHS, NICE, UK, keytruda, lung cancer, pharma
MSD’s Keytruda (pembrolizumab) has secured recommendation from NICE for inclusion on the Cancer Drugs Fund (CDF) in combination with chemotherapy …
NICE recommends Pierre Fabre’s Nerlynx in adjuvant HER2+ breast cancer
August 7, 2019Research and Development, Sales and Marketing Cancer, NCIE, NHS, Nerlynx, Pierre Fabre, UK, breast cancer
Pierre Fabre’s Nerlynx (neratinib) has been recommended by NICE as a new option for NHS patients with early hormone-receptor-positive, human …
NICE reject Clovis Oncology’s ovarian cancer drug Rubraca
August 6, 2019Manufacturing and Production NHS, NICE, Rubraca, UK, guidance, pharma
Britain’s cost-effectiveness body NICE has chosen not to recommend Clovis Oncology’s cancer drug Rubraca (rucaparib). On 6 August, NICE issued …
Top UK doctors warn Boris Johnson that no-deal Brexit would cause key cancer therapy supply shortages
August 2, 2019Manufacturing and Production, Medical Communications Cancer, NHS, UK, brexit, pharma
Top doctors from some of the UK’s foremost nuclear medicine associations have written a letter to recently-anointed Prime Minister Boris …
Bayer’s Xarelto combo greenlighted by NICE for reducing CV events in artery disease
August 1, 2019Sales and Marketing NHS, NICE, UK, Xarelto, cardiovascular disease, pharma
NICE has awarded final appraisal recommendation to Bayer’s Xarelto (rivaroxaban) at a dosage of 2.5mg twice daily in combination with …
The patient is always right: Extracting the full value of PROMs
July 29, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, PROs, UK, feature, patient reported outcomes, patient-reported outcomes, pharma
Patient-reported outcomes measures are an invaluable tool in ensuring that the patient remains in the driving seat when it comes …
AstraZeneca’s Lynparza approved via Cancer Drugs Fund for BRCA+ gynaecological cancers
July 26, 2019Medical Communications, Sales and Marketing AstraZeneca, Cancer, Cancer Drugs Fund, NHS, NICE, UK, lynparza, pharma
NICE has published final guidance which approves AstraZeneca’s Lynparza (olaparib) for use on the NHS as a maintenance therapy for …
NICE to review its decision making processes
July 22, 2019Sales and Marketing Cost, NHS, NICE, UK, britain, pharma
Britain’s cost-effectiveness body NICE has said it will review the methods it uses to develop guidance on drugs, medical devices, …
Government spend £9.2 billion on private healthcare providers for NHS in 2018-19
July 22, 2019Sales and Marketing DHSC, NHS, UK, health, healthcare, politics, private providers
The Department of Health and Social Care paid £9.2 billion to private providers in the year prior to 31 March …
Top Ten most popular articles on Pharmafile.com this week!
July 12, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HPV, NHS, NICE, Novartis, Pfizer, Trump, pharma, vaccines
This week’s most popular story covered news of Trump’s claims that he will introduce an executive order to ensure the …
NHS partners with Amazon to offer health information through Alexa
July 11, 2019Medical Communications Alexa, NHS, NHS LOng term plan, amazon, digitalisation, pharma, privacy
The NHS is collaborating with e-commerce giant Amazon to provide health information through the voice-activated, ‘virtual assistant’ Alexa. Patients will …
NHS to try out new subscription style payment model to pay for antibiotics
July 9, 2019Research and Development AMR, NHS, UK, health, payment models, pharma
The NHS has said it will test the world’s first subscription style payment model to pay for antibiotics. Britain’s National …
NICE recommends Alnylam’s Onpattro for inherited hATTR amyloidosis
July 9, 2019Manufacturing and Production, Sales and Marketing Alnylam, NHS, Onpattro, UK, hATTR amyloidosis, pharma
It’s good news for UK patients as it emerges that the National Institute of Health and Care Excellence has passed …
NICE recommends Pfizer’s Vizimpro, rejects AstraZeneca’s Tagrisso, in non-small cell lung cancer
July 5, 2019Medical Communications, Sales and Marketing Cancer, NHS, NICE, Pfizer, UK, Vizimpro, lung cancer, pharma
NICE has announced its decision to recommend Pfizer’s Vizimpro (Dacomitinib) in the treatment of non-small-cell lung cancer (NSCLC) – a …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
